Immix Biopharma prices 11,363,637 share offering at $11.00 raising $125 million gross
Immix Biopharma priced an underwritten offering of 11,363,637 common shares at $11.00 each, for gross proceeds of about $125 million before underwriting discounts and expenses. Closing is expected on or about Sept. 30, 2026.
Story updates
11:11:18 AM UTC
SquawkNews
Sept 29 (Reuters) — Immix Biopharma, Inc.: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock Immix Biopharma, - Prices 11,363,637 Shares At $11 Per Share Immix Biopharma, - Net Proceeds To Fund Nxc-201 Development, Working Capital, Corporate Purposes Source text:... Further company coverage: IMMX.O (Reuters.Briefs@thomsonreuters.com;;)